- Filed
- Mar 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 28, 2025 | 83.88M sh |
| Short Term Investments | Q2 2025 · Jan 31, 2025 | $471.47M |
| Short Term Investments | Q2 2025 · Jul 31, 2024 | $455.58M |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $697.49M |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $547.99M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $558.68M |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $837.64M |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $1.27B |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $883.56M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $1.48B |
| Current Assets | Q2 2025 · Jul 31, 2024 | $1.3B |
| Total Assets | Q2 2025 · Jan 31, 2025 | $2.54B |
| Total Assets | Q2 2025 · Jul 31, 2024 | $2.23B |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 83.31M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 81.91M sh |
| Capex | Q2 2025 · Jan 31, 2024 | $3.99M |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | −$2.83M |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | $1.26B |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $1.21B |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.2B |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.12 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.21 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.12 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.21 |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $40.18M |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $79.2M |
| Rd Expense | Q2 2025 · Jan 31, 2024 | $65.46M |
| Rd Expense | Q2 2025 · Jan 31, 2024 | $127.93M |
| Net Income | Q2 2025 · Jan 31, 2024 | $9.69M |
| Net Income | Q2 2025 · Jan 31, 2024 | −$17.38M |
| Net Income | Q2 2025 · Oct 31, 2023 | −$27.07M |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$12.41M |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$46.19M |
| Gross Profit | Q2 2025 · Jan 31, 2024 | $142.41M |
| Gross Profit | Q2 2025 · Jan 31, 2024 | $254.7M |
| Revenue | Q2 2025 · Jan 31, 2024 | $240.9M |
| Revenue | Q2 2025 · Jan 31, 2024 | $448.3M |